BPMC
Price
$80.27
Change
-$1.78 (-2.17%)
Updated
Apr 10 closing price
Capitalization
5.24B
20 days until earnings call
CGEN
Price
$1.21
Change
-$0.07 (-5.47%)
Updated
Apr 10 closing price
Capitalization
112.31M
27 days until earnings call
Ad is loading...

BPMC vs CGEN

Header iconBPMC vs CGEN Comparison
Open Charts BPMC vs CGENBanner chart's image
Blueprint Medicines
Price$80.27
Change-$1.78 (-2.17%)
Volume$1.27M
Capitalization5.24B
Compugen
Price$1.21
Change-$0.07 (-5.47%)
Volume$387.54K
Capitalization112.31M
BPMC vs CGEN Comparison Chart
Loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPMC vs. CGEN commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMC is a Hold and CGEN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 11, 2025
Stock price -- (BPMC: $80.27 vs. CGEN: $1.21)
Brand notoriety: BPMC and CGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMC: 115% vs. CGEN: 90%
Market capitalization -- BPMC: $5.24B vs. CGEN: $112.31M
BPMC [@Biotechnology] is valued at $5.24B. CGEN’s [@Biotechnology] market capitalization is $112.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $263.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMC’s FA Score shows that 0 FA rating(s) are green whileCGEN’s FA Score has 1 green FA rating(s).

  • BPMC’s FA Score: 0 green, 5 red.
  • CGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, both BPMC and CGEN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPMC’s TA Score shows that 4 TA indicator(s) are bullish while CGEN’s TA Score has 3 bullish TA indicator(s).

  • BPMC’s TA Score: 4 bullish, 5 bearish.
  • CGEN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both BPMC and CGEN are a bad buy in the short-term.

Price Growth

BPMC (@Biotechnology) experienced а -10.82% price change this week, while CGEN (@Biotechnology) price change was -14.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.33%. For the same industry, the average monthly price growth was -17.76%, and the average quarterly price growth was -19.66%.

Reported Earning Dates

BPMC is expected to report earnings on Jul 30, 2025.

CGEN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-7.33% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($5.24B) has a higher market cap than CGEN($112M). BPMC YTD gains are higher at: -7.968 vs. CGEN (-20.915). BPMC has higher annual earnings (EBITDA): 19.2M vs. CGEN (-14.41M). BPMC has more cash in the bank: 615M vs. CGEN (103M). CGEN has less debt than BPMC: CGEN (2.91M) vs BPMC (469M). BPMC has higher revenues than CGEN: BPMC (509M) vs CGEN (27.9M).
BPMCCGENBPMC / CGEN
Capitalization5.24B112M4,681%
EBITDA19.2M-14.41M-133%
Gain YTD-7.968-20.91538%
P/E RatioN/A64.00-
Revenue509M27.9M1,824%
Total Cash615M103M597%
Total Debt469M2.91M16,106%
FUNDAMENTALS RATINGS
BPMC vs CGEN: Fundamental Ratings
BPMC
CGEN
OUTLOOK RATING
1..100
5955
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
79
Overvalued
PROFIT vs RISK RATING
1..100
71100
SMR RATING
1..100
9392
PRICE GROWTH RATING
1..100
7286
P/E GROWTH RATING
1..100
4816
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CGEN's Valuation (79) in the Biotechnology industry is in the same range as BPMC (80). This means that CGEN’s stock grew similarly to BPMC’s over the last 12 months.

BPMC's Profit vs Risk Rating (71) in the Biotechnology industry is in the same range as CGEN (100). This means that BPMC’s stock grew similarly to CGEN’s over the last 12 months.

CGEN's SMR Rating (92) in the Biotechnology industry is in the same range as BPMC (93). This means that CGEN’s stock grew similarly to BPMC’s over the last 12 months.

BPMC's Price Growth Rating (72) in the Biotechnology industry is in the same range as CGEN (86). This means that BPMC’s stock grew similarly to CGEN’s over the last 12 months.

CGEN's P/E Growth Rating (16) in the Biotechnology industry is in the same range as BPMC (48). This means that CGEN’s stock grew similarly to BPMC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BPMCCGEN
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 19 days ago
73%
Bullish Trend 23 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
71%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ULE12.250.62
+5.33%
ProShares Ultra Euro
TBLL105.660.02
+0.02%
Invesco Short Term Treasury ETF
IBMO25.32-0.09
-0.35%
iShares iBonds Dec 2026 Term Muni Bd ETF
POWA77.52-1.33
-1.69%
Invesco Bloomberg Pricing Power ETF
AUGZ35.64-0.96
-2.62%
TrueShares Structured Outcome August ETF

BPMC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMC has been loosely correlated with ORIC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMC jumps, then ORIC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMC
1D Price
Change %
BPMC100%
-2.17%
ORIC - BPMC
44%
Loosely correlated
-8.10%
ARWR - BPMC
42%
Loosely correlated
-5.85%
DNLI - BPMC
41%
Loosely correlated
-2.80%
AXON - BPMC
41%
Loosely correlated
-1.53%
TECH - BPMC
41%
Loosely correlated
-8.90%
More